Filtered By:
Specialty: Cardiology
Drug: Beta-Blockers

This page shows you your search results in order of date. This is page number 13.

Order by Relevance | Date

Total 184 results found since Jan 2013.

The risk of resting heart rate on vascular events and mortality in vascular patients
Conclusions: Elevated RHR is associated with increased risk for mortality but not for myocardial infarction or stroke in patients with manifest vascular diseases irrespective of location of vascular disease.
Source: International Journal of Cardiology - January 10, 2013 Category: Cardiology Authors: Remy H.H. Bemelmans, Yolanda van der Graaf, Hendrik M. Nathoe, Annemarie M.J. Wassink, Joris W.P. Vernooij, Wilko Spiering, Frank L.J. Visseren, on behalf of the SMART study group Tags: Original Articles Source Type: research

Peripheral artery disease and outcomes after myocardial infarction: An individual-patient meta-analysis of 28,771 patients in CAPRICORN, EPEHESUS, OPTIMAAL and VALIANT
Abstract: Objectives: To examine the prevalence of peripheral artery disease (PAD) and the relationship between PAD and cardiovascular (CV) outcomes in subjects with left ventricular systolic dysfunction, heart failure or both after acute myocardial infarction (MI).Background: PAD is associated with poorer prognosis in patients with stable and unstable coronary heart disease but whether PAD is associated with worse outcomes following substantial acute MI is unknown.Methods: Univariate and multivariate Cox proportional hazards modelling was used to compare clinical outcomes in an individual-patient meta-analysis of 4 trials...
Source: International Journal of Cardiology - November 29, 2012 Category: Cardiology Authors: Sally C. Inglis, Judith Bebchuk, Sultan A. Al-Suhaim, Jessica Case, Marc A. Pfeffer, Scott D. Solomon, Yingxin (Rachel) Hou, Bertram Pitt, Henry J. Dargie, Ian Ford, John Kjekshus, Faiez Zannad, Kenneth Dickstein, John J.V. McMurray Tags: Original Articles Source Type: research

Early intravenous beta-blockers in patients with acute coronary syndrome—A meta-analysis of randomized trials
Conclusions: Intravenous beta-blockers early in the course of appropriate patients with ACS appears to be associated with significant reduction in the risk of short-term cardiovascular outcomes, including a reduction in the risk of all-cause mortality.
Source: International Journal of Cardiology - November 19, 2012 Category: Cardiology Authors: Saurav Chatterjee, Debanik Chaudhuri, Rajesh Vedanthan, Valentin Fuster, Borja Ibanez, Sripal Bangalore, Debabrata Mukherjee Tags: Original Articles Source Type: research

Ivabradine is BEAUTIFUL in concurrent acute coronary syndrome and stroke
We report the safe use of oral ivabradine in 2 patients with concurrent ACS and stroke, achieving heart rate reduction and angina relief without affecting blood pressure.
Source: International Journal of Cardiology - September 20, 2012 Category: Cardiology Authors: Pow-Li Chia, David Foo Tags: Online letters to the Editor Source Type: research